Donor/recipient ascending aortic diameter ratio as a novel potential metric for donor selection and improved clinical outcomes in heart transplantation: a propensity score-matched study [PDF]
Frontiers in Cardiovascular Medicine, 2023 BackgroundDonor/recipient size matching is paramount in heart transplantation. Body weight, height, body mass index, body surface area, and predicted heart mass (PHM) ratios are generally used in size matching.
Matiullah Masroor +4 more
doaj +2 more sources
An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis [PDF]
Frontiers in Immunology, 2021 Fecal microbiota transplantation (FMT) is an effective procedure against Clostridioides difficile infection (CDI), with promising but still suboptimal performance in other diseases, such as ulcerative colitis (UC). The recipient’s mucosal immune response
Manuel Ponce-Alonso +17 more
doaj +2 more sources
Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire [PDF]
Frontiers in Immunology, 2023 Natural killer (NK) cell-based adoptive immunotherapy in leukemia patients is an emerging field of interest based on clinical evidence of efficacy and safety. Elderly acute myeloid leukemia (AML) patients have been successfully treated with NK cells from
Raffaella Meazza +18 more
doaj +2 more sources
Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation [PDF]
Frontiers in ImmunologyIntroductionThe human leukocyte antigen (HLA) evolutionary divergence (HED) reflects immunopeptidome diversity and has been shown to predict the response of tumors to immunotherapy.
Xing-Yu Cao +4 more
doaj +2 more sources
Review 1: Lung transplant-from donor selection to graft preparation. [PDF]
J Anesth, 2020 For various end-stage lung diseases, lung transplantation remains one of the only viable treatment options. While the demand for lung transplantation has steadily risen over the last few decades, the availability of donor grafts is limited, which have ...
Jin Z +7 more
europepmc +2 more sources
KIR Donor Selection: Feasibility in Identifying better Donors [PDF]
Biology of Blood and Marrow Transplantation, 2019 We previously reported that acute myelogenous leukemia (AML) transplants using killer cell immunoglobulin-type receptor (KIR) B haplotype better or best (≥2 B activating gene loci ± Cen B/B) unrelated donors (URDs) yield less relapse and better survival.
Daniel Weisdorf +19 more
openaire +3 more sources
Selection of donors for living donor liver transplantation [PDF]
Liver Transplantation, 2003 Key points 1. The donor evaluation is performed in three staged phases to disqualify inappropriate candidates as early as possible in the process. 2. Approximately half the potential transplant recipients are unable to identify a suitable donor for evaluation. 3.
James F. Trotter
openalex +4 more sources
Donor selection in the modern era
Annals of Cardiothoracic Surgery, 2018 The growing disparity between the supply of donor hearts for transplantation and the demand for such organs has led to liberalization of the criteria for donor heart acceptance over the past few decades.
Kiran K. Khush
openalex +3 more sources
Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations [PDF]
Stem Cells International, 2017 Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for many diseases. Stem cells may be obtained from different sources: mobilized peripheral blood stem cells, bone marrow, and umbilical cord blood.
I. Riezzo +5 more
semanticscholar +6 more sources
The Potential Significance of ABO Genotyping for Donor Selection in Kidney Transplantation [PDF]
Frontiers in Immunology, 2020 BackgroundThe ABO blood group system is clinically important in kidney transplantation, but ABO genotyping fails to attract sufficient attention in some countries and regions.
Yi Zhou +14 more
doaj +2 more sources